بدائل البحث:
linear decrease » linear increase (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
b large » a large (توسيع البحث), _ larger (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
b large » a large (توسيع البحث), _ larger (توسيع البحث)
-
1
<b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>"
منشور في 2025"…<p dir="ltr">The CSV file 'Eyreetal_DrainingVein_SourceData' contains the averaged time series traces and extracted metrics from individual experiments used across Figures 1-5 in the manuscript "Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins". The following acronyms included in the CSV file are defined as follows: Hbt is total hemoglobin, Art is artery region, DV is draining vein region, WV is whisker vein region, SEM is standard error mean, TS is time series, max peak is maximum peak, min peak is minima, AUC is area under the curve, WT is wild-type, AD is Alzheimer's disease, ATH is atherosclerosis and MIX is mixed AD/atherosclerosis. …"
-
2
-
3
-
4
ECoG timescales decrease during spatial attention.
منشور في 2025"…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …"
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
منشور في 2025الموضوعات: -
15
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
منشور في 2025الموضوعات: -
16
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
منشور في 2025الموضوعات: -
17
-
18
-
19
-
20
Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.
منشور في 2025الموضوعات: